Powered by

Home Trending News Deepinder Goyal hints at aging breakthrough with Continue Research, says, “one element of our environment may hold the key”

Deepinder Goyal hints at aging breakthrough with Continue Research, says, “one element of our environment may hold the key”

Deepinder Goyal’s Continue Research is backing studies into human aging with $25 million. Goyal says a simple environmental factor could hold the key to slowing aging.

By Anushree Ajay
New Update
Zomato CEO Deepinder Goyal

Zomato CEO Deepinder Goyal

Listen to this article
0.75x1x1.5x
00:00/ 00:00

Deepinder Goyal, co-founder of Zomato, recently shared a bold message on social media.

Advertisment

“Once upon a time, people believed the Earth was flat. And then they didn’t. Then they believed the sun revolved around the Earth. Until they didn’t,” he wrote. 

He added, “Humanity has built rockets, sequenced genomes, and cloned cells. Yet, in all our brilliance, we may have missed something glaringly simple.”

Goyal teased that Continue Research has found a factor in our environment that might play a major role in slowing human aging. He promised to share the full details in 48 hours, raising curiosity in the scientific and health communities.

How Deepinder Goyal is changing aging research

Goyal says that for the past two years, his team at Continue Research has been looking for a simple pattern behind human aging. 

“We tried desperately to disprove it. We couldn’t,” he wrote. 

According to reports, this research could change the way scientists think about aging if the results hold up.

The research focuses on simple points in the human body that, if influenced, could have a big impact on how we age. Goyal emphasized that Continue Research is backing scientists who ask clear, basic questions about biology. 

“Today, we are expanding Continue Research to include a $25 million fund to support researchers across the world who dare to ask simpler questions than anyone else,” he said.

Also Read: Groww opens at 14% above IPO price and closes at 29% premium ; market capitalization climbs to ₹91,500 Crore on debut

Deepinder Goyal’s $25 million Continue Research

Continue Research was started by Deepinder Goyal two years ago to study human aging in a new way. The goal is to find simple ways to influence the body’s aging process and improve healthy lifespan.

The research is fully funded by Goyal’s personal capital of around ₹220 crore ($25 million). The project is not a company or startup. It is purely focused on scientific research. 

The mission is to help humans live healthier for longer, with the idea of reaching lifespans up to 180 years. Continue Research operates independently from Goyal’s other venture, Eternal.

Goyal’s statements and the funding show he is serious about supporting research that challenges current thinking in aging science. With the 48-hour countdown ticking, many are waiting to see what environmental factor might be key to slowing aging.

Also Read: Tata Motors CV debuts at 28% premium on stock market; lists at ₹335 on NSE and ₹330.25 on BSE after demerger